STATE STREET CORP - 31 Dec 2025 SCHEDULE 13G Report for BIOCRYST PHARMACEUTICALS INC COMMON STOCK (BCRX)

Filing Manager: STATE STREET CORP
Reporting Manager: STATE STREET CORPORATION
Security: BIOCRYST PHARMACEUTICALS INC COMMON STOCK
Symbol: BCRX
Shares outstanding: 208,928,509 shares
Disclosed Ownership: 11,073,211 shares
Ownership: 5.3%
Form type: SCHEDULE 13G
Filing time: 09 Feb 2026, 06:19:43 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
STATE STREET CORPORATION	5.3%	11,073,211	0	10,457,690	ELIZABETH SCHAEFER	SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER